Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Dermatology

Journal Scan / Research · July 25, 2024

Safety of Treatment With Anti–IL-4/IL-13 Agents vs JAK Inhibitors in Patients With Atopic Dermatitis

Journal of the American Academy of Dermatology

 

Additional Info

Journal of the American Academy of Dermatology
Comparative Safety Analysis of Anti-IL-4/IL-13 Inhibitors and JAK Inhibitors in Atopic Dermatitis
J Am Acad Dermatol 2024 Jul 04;[EPub Ahead of Print], A Bao, HJ Su, J Wan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading